Investment

Details

Screening Program
  • RFP Year
    2020
  • Awarded Amount
    $122,013
  • Disease
    Malaria
  • Intervention
    Drug
  • Development Stage
    Hit Identification
  • Collaboration Partners
    Daiichi Sankyo, Inc., Medicines for Malaria Venture (MMV)